Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Paolo F. Schena"'
Autor:
Annalisa Teutonico, Domenica Leogrande, Carmen Capobianco, Paolo F. Schena, Salvatore Di Paolo
Publikováno v:
Journal of the American Society of Nephrology. 17:2236-2244
Overactivation of the mammalian target of rapamycin (mTOR) branch downstream of the phosphatidylinositol 3-kinase-AKT pathway critically modulates insulin and growth factor signaling by insulin receptor substrates (IRS). On the basis of in vitro stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba54c559f551293ae75842cdb19f0d1a
https://doi.org/10.1681/asn.2006030196
https://doi.org/10.1681/asn.2006030196
Publikováno v:
Journal of the American Society of Nephrology. 16:3128-3135
Cyclosporine A (CsA) and tacrolimus have been associated with an increased risk for diabetes after transplantation, whereas sirolimus is deemed to be devoid of any effect on glucose metabolism. This study was performed to investigate the effect of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2041c3aa024c0724385ab98be4bcdf24
https://doi.org/10.1681/asn.2005050487
https://doi.org/10.1681/asn.2005050487
Autor:
Annalisa Teutonico, Salvatore Di Paolo, Pasquale Ditonno, Michele Battaglia, Antonio Schena, Giovanni Stallone, Paolo F. Schena, Giuseppe Grandaliano, Barbara Infante
Publikováno v:
Nephrology Dialysis Transplantation. 19:2107-2112
Background. Cyclosporin (CsA) level obtained 2 h after the morning dose (C2) has been shown to accurately predict total CsA exposure and acute rejection (AR) risk, whereas conventional trough levels (C0 )d o not. The impact of C2 monitoring on long-t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ed66f78b8afaf7eaa7262a2f9f759b3
https://doi.org/10.1093/ndt/gfh344
https://doi.org/10.1093/ndt/gfh344
Publikováno v:
American journal of kidney diseases : the official journal of the National Kidney Foundation. 49(3)
Background The clinical challenge for the application of rapamycin and its derivatives as anticancer drugs is the ability to prospectively identify which tumors will be sensitive to mammalian target of rapamycin (mTOR) inhibition. The present study i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5be6a00c5a5e86f27f67ee58f7f75261
https://pubmed.ncbi.nlm.nih.gov/17336708
https://pubmed.ncbi.nlm.nih.gov/17336708
Autor:
Salvatore Di Paolo, Domenica Leogrande, Annalisa Teutonico, Elena Ranieri, Marilisa Saldarelli, Loreto Gesualdo, Paolo F. Schena
Publikováno v:
American Journal of Kidney Diseases. 51:531-532
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62bf2edc34b694aa7ce2a16d7d9c9236
https://doi.org/10.1053/j.ajkd.2007.12.027
https://doi.org/10.1053/j.ajkd.2007.12.027
Autor:
Michele Battaglia, Giuseppe Grandaliano, Paolo F. Schena, Gennaro Annunziata, Giuseppe Castellano, Michele Rossini, Antonella Loverre, Pasquale Ditonno, Vincenzo Montinaro, Rita Melchiorre, Mohamed Daha, Maurice Mannesse, Antonio Crovace, Sandra van Wetering
Publikováno v:
Molecular Immunology. 45:4158
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::06d7486bdc3f29c7c6a8365de05aae96
https://doi.org/10.1016/j.molimm.2008.08.188
https://doi.org/10.1016/j.molimm.2008.08.188
Autor:
Salvatore di Paolo, Annalisa Teutonico, Giovanni Stallone, Barbara Infante, Antonio Schena, Giuseppe Grandaliano, Michele Battaglia, Pasquale Ditonno, Paolo F. Schena
Publikováno v:
Nephrology Dialysis Transplantation; Aug2004, Vol. 19 Issue 8, p2107-2112, 6p